Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices 27185 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: May 2, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–09755 Filed 5–5–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–991] 

Bulk Manufacturer of Controlled 

Substances Application: Patheon 

Pharmaceuticals Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Patheon Pharmaceuticals Inc. 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTAL INFORMATION listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before July 5, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 5, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on February 3, 2022, 

Patheon Pharmaceuticals Inc., 2110 East 

Galbraith Road, Cincinnati, Ohio 

45237–1625, applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid .... 2010 I 

The company plans to manufacture 

the above-listed controlled substance as 

Active Pharmaceutical Ingredient (API) 

that will be further synthesized into 

Food and Drug Administrationapproved dosage forms. No other 

activities for this drug code are 

authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09779 Filed 5–5–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB 1140–0066] 

Agency Information Collection 

Activities; Proposed eCollection of 

eComments Requested; Manufacturers 

of Ammunition, Records and 

Supporting Data of Ammunition 

Manufactured and Disposed of 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives, Department of 

Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Bureau of Alcohol, 

Tobacco, Firearms and Explosives 

(ATF), Department of Justice (DOJ), will 

submit the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

(IC) is also being published to obtain 

comments from the public and affected 

agencies. 

DATES: Comments are encouraged and 

will be accepted for 60 days until July 

5, 2022. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

regarding the estimated public burden 

or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions, or 

additional information, contact: Jason 

Gluck, Firearms Industry Programs 

Branch, Firearms Explosives Industries 

Division, Enforcement Programs 

Services, by mail at 99 New York Ave. 

NE, Washington, DC 20226, by email at 

FIPB-informationcollection@atf.gov, or 

telephone at 202–648–7190. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and, if so, how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection 

(check justification or form 83): 

Extension without Change of a 

Currently Approved Collection. 


JSPEARS on DSK121TN23PROD with NOTICES1